Dr Mohammad Afshar
Chief Executive Officer (CEO)
Clinical & Biomarker Data Analytics
Ariana Pharma
United States of America
Biography
Mohammad is the President and CEO of Ariana Pharmaceuticals and founded the company in 2003. Prior to this, Mohammad was one of the founders and the Director of Drug Design and IT at RiboTargets, Cambridge, UK, leading the computer aided discovery of novel anti infective and oncology molecules. Before joining RiboTargets, Mohammad held several positions in academic institutions including the Department of Chemistry at the University of York, UK, and the CRBM of the CNRS in France. He holds a Medical Degree (DCEM), MPhil in Computer Science (DEA), a PhD in structural biochemistry and a “Habilitation doctorate” (HDR) from the Faculty of Medicine of the University of Montpellier, France. He is currently involved with a number of charities, including the Cystic Fibrosis foundation.
Research Interest
Advanced, clinical and biomarker data analytics technology, multi-parametric data analysis, clincial data analysis service